Chicago Partners Investment Group’s Avanos Medical AVNS Stock Holding History

Chicago Partners Investment Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-76	Closed	-$4K	–	361
2018 Q3	$4K	Buy	76 +39	+105%	+$2.51K	﹤0.01%	936
2018 Q2	$2K	Hold	37	–	–	﹤0.01%	911
2018 Q1	$2K	Hold	37	–	–	﹤0.01%	891
2017 Q4	$2K	Buy	37 +12	+48%	+$552	﹤0.01%	849
2017 Q3	$1K	Sell	25 -25	-50%	-$1.07K	﹤0.01%	935
2017 Q2	$2K	Buy	+50	New	+$1.89K	﹤0.01%	620
2016 Q3	–	Sell	-212	Closed	-$7K	–	493
2016 Q2	$7K	Hold	212	–	–	﹤0.01%	384
2016 Q1	$6K	Hold	212	–	–	﹤0.01%	375
2015 Q4	$7K	Hold	212	–	–	﹤0.01%	421
2015 Q3	$6K	Hold	212	–	–	﹤0.01%	374
2015 Q2	$9K	Sell	212 -17	-7%	-$763	﹤0.01%	347
2015 Q1	$10K	Buy	229 +17	+8%	+$788	﹤0.01%	349
2014 Q4	$10K	Buy	+212	New	+$8.33K	﹤0.01%	362

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Chicago Partners Investment Group's AVNS Position: Q4 2018 in Review

Chicago Partners Investment Group sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 76 shares — an estimated $4K sold.

Chicago Partners Investment Group first reported a position in AVNS in Q4 2014 and held it in 13 quarters. The position peaked at $10K in Q1 2015. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

Chicago Partners Investment Group reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
Chicago Partners Investment Group sold 76 Avanos Medical shares in Q4 2018, an estimated $4K.
Chicago Partners Investment Group first reported a position in Avanos Medical in Q4 2014 and held it in 13 quarters.
Chicago Partners Investment Group's Avanos Medical position peaked at $10K in Q1 2015.
350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Chicago Partners Investment Group's 13F filing for Q4 2018, filed 11 Jan 2019.